Baseline characteristics and clinical outcomes of patients with type 2 diabetes and cardiovascular disease treated with GLP-1 receptor agonists and SGLT2 inhibitors
Event:
ESC Congress 2025
Topic:
Diabetes and the Heart
Session:
Cardiometabolic and diabetes
